GSK plc
Pfizer
Novartis
AstraZeneca
Bayer
Hoechst AG
Bristol Myers Squibb
Roche
Merck & Co.
Amgen
Boehringer Ingelheim
Novo Nordisk
Rhône-Poulenc
Merck Group
Eli Lilly and Company
Benzinga via Yahoo
Sanofi Raises 2024 Profit Outlook On Strong Q2 Earnings, Blockbuster Drug Dupixent Sees Strong Demand
3 days ago
Reuters via Yahoo
Sanofi lifts 2024 profit forecast on strength in Dupixent, new products
4 days ago
ETF DAILY NEWS
Sanofi (NASDAQ:SNY) Upgraded by StockNews.com to Strong-Buy
Separately, Argus raised their price objective on shares of Sanofi from $55.00 to $60.00 and gave the stock a “buy” rating in a report on Friday. 7 Stocks to Buy and Hold Forever NASDAQ SNY ...
18 hours ago
WHTC 1450 Holland
Sanofi bumps up full-year forecast after strong Q2 profit
BioPharma Dive via Yahoo
Sanofi’s immunology bet starts to pay off
WFMZ Eastern Pennsylvania and Western New Jersey
Sanofi vaccine sales down for the quarter
The Motley Fool via Yahoo
Sanofi (SNY) Q2 2024 Earnings Call Transcript
Sanofi (SNY) to Release Quarterly Earnings on Thursday
Sanofi (NASDAQ:SNY – Get Free Report) is scheduled to be releasing its earnings data before the market opens on Thursday, July 25th. Analysts expect Sanofi to post earnings of $0.87 per share ...
6 days ago
Investing.com
Sanofi lifts FY guidance after strong Q2 results By Investing.com
Zacks
Sanofi (SNY) Q2 Earnings Beat, Sales Miss, 2024 View Raised
Free Report) reported second-quarter 2024 adjusted earnings of 93 cents per American depositary share, which beat the Zacks Consensus Estimate of 88 cents per share. Earnings of €1.73 per share ...
View all
French pharmaceutical company
sanofi.com
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. Wikipedia
More on Yahoo Finance